A Study to Evaluate the Efficacy and Safety of AD-218

Clinical trial NCT05400317 · RECRUITING

Trial details

NCT number: NCT05400317
Sponsor: Addpharma Inc.
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Mixed Dyslipidemia

Start date: 2022-07-27
Primary completion: 2026-03-31
Enrollment: 520

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.